Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eide

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 1, 2013
Malignant melanoma--diagnosis, treatment and follow-up in NorwayJürgen Geisler, Ingeborg M Bachmann, Marta Nyakas, et al.
Oncotarget|December 2, 2015
Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinomaHui-Wen Lue, Brook Cole, Soumya A M Rao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2008
SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinibThomas O'Hare, Christopher A Eide, Jeffrey W Tyner, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard TherapiesStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Blood|September 13, 2011
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemiaThomas O'Hare, Matthew S Zabriskie, Christopher A Eide, et al.
Cold Spring Harbor Molecular Case Studies|October 28, 2022
Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemiaMara W Rosenberg, Samantha L Savage, Christopher A Eide, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618IJulia E Maxson, Samuel B Luty, Jason D MacManiman, et al.
Cancer Research|April 21, 2011
The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profileChristopher A Eide, Lauren T Adrian, Jeffrey W Tyner, et al.
Nature Genetics|December 22, 2005
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunctionHelge Raeder, Stefan Johansson, Pål I Holm, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 3, 2026
International validation of a staging system for ciliary body and choroidal melanomas using estimated tumour volumeSacha Nahon-Estève, Jean-Pierre Caujolle, Célia Maschi, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 1, 2013
Malignant melanoma--diagnosis, treatment and follow-up in NorwayJürgen Geisler, Ingeborg M Bachmann, Marta Nyakas, et al.
Oncotarget|December 2, 2015
Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinomaHui-Wen Lue, Brook Cole, Soumya A M Rao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 28, 2008
SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinibThomas O'Hare, Christopher A Eide, Jeffrey W Tyner, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard TherapiesStephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Blood|September 13, 2011
The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemiaThomas O'Hare, Matthew S Zabriskie, Christopher A Eide, et al.
Cold Spring Harbor Molecular Case Studies|October 28, 2022
Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemiaMara W Rosenberg, Samantha L Savage, Christopher A Eide, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618IJulia E Maxson, Samuel B Luty, Jason D MacManiman, et al.
Cancer Research|April 21, 2011
The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profileChristopher A Eide, Lauren T Adrian, Jeffrey W Tyner, et al.
Nature Genetics|December 22, 2005
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunctionHelge Raeder, Stefan Johansson, Pål I Holm, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 3, 2026
International validation of a staging system for ciliary body and choroidal melanomas using estimated tumour volumeSacha Nahon-Estève, Jean-Pierre Caujolle, Célia Maschi, et al.
Pageof 12